Avstera Therapeutics Corp.
June 16, 2025
Company Presentation
Metabolic Diseases
Avstera Therapeutics is a biotech company based in Malvern, PA developing next gen best-in-class oral selective HDAC6 inhibitors targeting a myriad of diseases including obesity, cancer and other cardio related indications.
Company HQ City:
Malvern
Company HQ State:
PA
Company HQ Country:
United States
Year Founded:
2021
Lead Product in Development:
Phase I Ready
CEO
Karthik Musunuri
Year Founded
2021
Development Phase of Lead Product
Phase I
Number of Unlicensed Products Looking for Licensing
3
What is your next catalyst (value inflection) update?
June 2025
Website
www.avstera.com
Primary Speaker
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}